The Effect of Fish Oil Supplementation on Vocal Performance

NCT ID: NCT05141045

Last Updated: 2021-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

43 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-08

Study Completion Date

2021-05-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to determine if use of omega-3 PUFA supplement in combination with a singer's training regimen enhances training adaptations and body composition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Voice Range Profile Reflux Symptom Index Evaluation of Ability to Sing Easily Body Composition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

omega-3 PUFA supplement

omega-3 PUFA supplement, 3.0 grams per day

Group Type EXPERIMENTAL

omega-3 PUFA supplement

Intervention Type DIETARY_SUPPLEMENT

participants were instructed to take 3.0 grams per day of omega-3 PUFA supplement

placebo

safflower oil, 3.0 grams per day

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type DIETARY_SUPPLEMENT

placebo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

omega-3 PUFA supplement

participants were instructed to take 3.0 grams per day of omega-3 PUFA supplement

Intervention Type DIETARY_SUPPLEMENT

placebo

placebo

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Apparently healthy college vocal performers (male and female of all ethnicities) \*Between the ages of 18-28 years
* Majoring in classical voice in the Baylor University School of Music or musical theatre in the Baylor University Department of Theatre Arts.

Exclusion Criteria

* Previously diagnosed with a voice disorder
* Vegans
* Smokers
* Allergic to fish, shellfish or safflower oil
* Have been taking daily FO n-3 supplement within the past three months, or any supplement known to effect muscle biology (e.g. creatine).
Minimum Eligible Age

18 Years

Maximum Eligible Age

28 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Baylor University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

LesLee Funderburk, PhD

Role: PRINCIPAL_INVESTIGATOR

Baylor University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Baylor University

Waco, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1708288-3

Identifier Type: -

Identifier Source: org_study_id